Journal of the Korean Ophthalmological Society 1996;37(8):1354-1359.
Published online August 1, 1996.
Effect of Levodopa on Visual Function in Amblyopia.
Jeong Hee Lee, Dong Gyu Choi
Department of Ophthalmology, Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea.
약시안에서 Levodopa의 치료효과
이정희(Jeong Hee Lee),최동규(Dong Gyu Choi)
Recently many attempts have been made to find a meaical treatment for amblyopes who failed or were stable to respond to conventional occlusion therapy. To evaluate the efficacy and tolerability of levodopa, double-masked placebocontrolled study was performed on 20 older children with strabismic and anisometropic amblyopia. 12 subjects received 2.0mg/0.5mg/kg of levodopa/benzerazide and 8 subjects received 2.0mg/kg of placebo(lactose). Snellen visual acuity, steroacuity, Worth 4 dot test were measured to assess efficacy at baseline, 1 and 5 hours after drug ingestion. Tolerance was assessed by questionnare. Log Snellen fraction in the amblyopic eyes of levodopa group improved by 0.1(one line), from an overall average of 0.49 to 0.39 at 1 hour and 5 hours after drug ingestion(p<0.01). No significant changes in visual acuity were found in the dominant eyes of levodopa group and in both eyes of placebo group. In levodopa group the improvements of stereoacuity (more than 1 step) were by 50% at 1 hour and 83% at 5 hours after drug ingestion, but in placebe group, only 13% at both 1 and 5 hours after. No changes in Worth 4 dot test were found in both levodopa group and placebo group. Side effects reported in the study were transient episodes of nausea, emesis and sleepiness, but similar between two groups. In conclusion, we found levodopa is efficacious in temporarily improving visual function in amblyopic eyes, and further investigation with a large number of patients and longer duration of follow up is needed.
Key Words: Amblyopia;Levodopa;Visual acuity;Stereoacuity;Worth 4 dot test

Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail:                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next